Megan E. Glise - 08 Nov 2024 Form 4 Insider Report for LUXFER HOLDINGS PLC (LXFR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2024, 07:35:47 UTC
Prior SEC filing
21 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Benjamin Coulson under Power of Attorney for Megan E. Glise

Key filing fact

Megan E. Glise filed Form 4 for LUXFER HOLDINGS PLC (LXFR) on 12 Nov 2024.

Key facts

  • This page summarizes Megan E. Glise's Form 4 filing for LUXFER HOLDINGS PLC (LXFR).
  • 13 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2024, 07:35.

Change

  • Previous filing in this sequence was filed on 21 Mar 2024.
  • Current net transaction value: -$25,652.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+691
Change %
+12%
Price
Shares after
6,277
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+447
Change %
+7.1%
Price
Shares after
6,724
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+475
Change %
+7.1%
Price
Shares after
7,199
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+846
Change %
+12%
Price
Shares after
8,045
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+922
Change %
+11%
Price
Shares after
8,967
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+180
Change %
+2%
Price
Shares after
9,147
Date
08 Nov 2024
Ownership
Direct
Footnotes
F1
LXFR transaction

Ordinary Shares

Tax liability

Transaction value
$25,652
Shares
-1,751
Change %
-19%
Price
$14.65
Shares after
7,396
Date
08 Nov 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-691
Change %
-100%
Price
Shares after
0
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
691
Exercise price
Footnotes
F1, F2
LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-447
Change %
-50%
Price
Shares after
448
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
447
Exercise price
Footnotes
F1, F3
LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-475
Change %
-33%
Price
Shares after
952
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
475
Exercise price
Footnotes
F1, F4
LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-846
Change %
-25%
Price
Shares after
2,541
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
846
Exercise price
Footnotes
F1, F5
LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-922
Change %
-100%
Price
Shares after
0
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
922
Exercise price
Footnotes
F1, F6
LXFR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-180
Change %
-50%
Price
Shares after
180
Date
08 Nov 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
180
Exercise price
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Megan E. Glise is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 7 footnotes

Footnote F1

Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.

Footnote F2

Represents the partial, accelerated vesting of time-based Restricted Stock Units awarded on March 15, 2021. The Restricted Stock Units would normally vest on March 15, 2025. The above figure includes 91 additional Restricted Stock Units accrued through November 8, 2024 related to dividend reinvestment rights.

Footnote F3

Represents the partial, accelerated vesting of time-based Restricted Stock Units awarded on March 14, 2022. The Restricted Stock Units would normally vest on March 14, 2025. In accordance with the terms of an Executive Severance and Change in Control Agreement entered into by the Reporting Person and the Issuer and arrangements made with respect to the Reporting Person's termination of employment with the Issuer (together, the "Agreement"), the remaining Restricted Stock Units will be forfeited and lapse. The above figure includes 47 additional Restricted Stock Units accrued through November 8, 2024 related to dividend reinvestment rights.

Footnote F4

Represents the partial, accelerated vesting of time-based Restricted Stock Units awarded on March 20, 2023. The Restricted Stock Units would normally vest on March 20, 2025. In accordance with the terms of the Agreement, the remaining Restricted Stock Units will be forfeited and lapse. The above figure includes 26 additional Restricted Stock Units accrued through November 8, 2024 related to dividend reinvestment rights.

Footnote F5

Represents the partial, accelerated vesting of time-based Restricted Stock Units awarded on March 18, 2024. The Restricted Stock Units would normally vest on March 18, 2025. In accordance with the terms of the Agreement, the remaining Restricted Stock Units will be forfeited and lapse. The above figure includes 49 additional Restricted Stock Units accrued through November 8, 2024 related to dividend reinvestment rights.

Footnote F6

Represents the accelerated grant and vesting of performance-based Restricted Stock Units (at 96% target, representing performance and a prorated number of Restricted Stock Units based on the number of days elapsed in the performance period) awarded on March 14, 2022. The performance-based Restricted Stock Units would normally be granted and vest on March 14, 2025 upon the achievement of an adjusted diluted EPS growth performance measure for the performance period ending December 31, 2024.

Footnote F7

Represents the accelerated grant and partial vesting of performance-based Restricted Stock Units (at 25% target, representing performance and a prorated number of Restricted Stock Units based on the number of days elapsed in the performance period) awarded on March 14, 2022. The performance-based Restricted Stock Units would normally be granted and vest in two equal annual instalments on March 14, 2025 and March 14, 2026 upon the achievement of a Total Shareholder Return (TSR) performance measure for the performance period ending December 31, 2024. In accordance with the terms of the Agreement, the remaining performance-based Restricted Stock Units will be forfeited and lapse.

SEC remarks

The Reporting Person voluntarily resigned from employment with the Issuer, effective November 1, 2024, and is no longer serving as General Counsel and Company Secretary. This Form 4 is being filed in conjunction with the vesting of derivative securities in accordance with the terms of an Executive Severance and Change in Control Agreement entered into by the Reporting Person and the Issuer and arrangements made with respect to the Reporting Person's termination of employment with the Issuer. This Form 4 is being filed as a voluntary exit Form 4, indicating that the Reporting Person is no longer subject to Section 16 reporting with respect to the the Issuer unless otherwise required by the Securities Exchange Act of 1934, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .